MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$14,893K
EPS
-$2.8
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
7,425
6,834
-417*
6,136
General and administrative
2,592
3,271
3,677*
2,809
Restructuring and asset impairment charges
5,077
-
-
-
Total operating expenses
15,094
10,105
3,259
8,945
Loss from operations
-15,094
-10,105
-3,259*
-8,945
Other income, net
202
309
565*
321
Net loss
-14,892
-9,796
-2,695*
-8,624
Unrealized gain on marketable securities
-1
-23
-8*
24
Total comprehensive loss
-14,893
-9,819
-2,704
-8,600
Basic EPS
-2.8
-1.87
-0.778
-3.22
Diluted EPS
-2.8
-1.87
-0.778
-3.22
Basic Average Shares
5,309,724
5,239,236
3,476,499
2,676,116
Diluted Average Shares
5,309,724
5,239,236
3,476,499
2,676,116
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$14,893K
(44.46%↑ Y/Y)
Net loss
-$14,892K
(44.45%↑ Y/Y)
Unrealized gain on
marketable securities
-$1K
(85.71%↑ Y/Y)
Other income, net
$202K
(-58.26%↓ Y/Y)
Loss from operations
-$15,094K
(44.69%↑ Y/Y)
Total operating
expenses
$15,094K
(-44.69%↓ Y/Y)
Research and development
$7,425K
(-69.18%↓ Y/Y)
Restructuring and asset
impairment charges
$5,077K
General and
administrative
$2,592K
(-19.03%↓ Y/Y)
Buy us a coffee
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC)